Singularity Biosciences is pioneering the next generation of regenerative wound care, orthopedic and spine biologics, including regenerative bone products, synthetic bone grafts, bone scaffolds, demineralized bone matrix and bone void fillers.
What sets Singularity Biosciences apart is our commitment to intellectual property translation and development. Unlike companies focused on commodity products, we target opportunities where we can secure exclusive rights to novel therapies, ensuring sustainable competitive advantages and meaningful advances in patient care.
Our focus is on advancing medical science and patient care through regenerative therapies that:
Deliver superior clinical outcomes compared to existing technologies.
Enhance efficiency in patient care delivery.
Pioneer innovative approaches to musculoskeletal treatment.
We offer a carefully curated suite of osteobiologics and regenerative tissue products for surgical applications, selected for their superior biological properties, ease-of-use and potential to improve operating room efficiency. Our wound care division specializes in advanced skin substitutes, providing cutting-edge solutions for complex wound management.
